01 7Poteligeo
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 129
2019 Revenue in Millions : 121
Growth (%) : 6
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 146
2020 Revenue in Millions : 129
Growth (%) : 27
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 184
2021 Revenue in Millions : 146
Growth (%) : 26
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 204
2022 Revenue in Millions : 184
Growth (%) : 25
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 18
2016 Revenue in Millions : 18
Growth (%) : 0
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 35
2017 Revenue in Millions : 17
Growth (%) : 105%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 119
2018 Revenue in Millions : 36
Growth (%) : 228
